A prospective, observational, open-label, multicentre study to investigate the daily treatment practice of ranibizumab in patients with neovascular age-related macular degeneration

F. van Asten, K.U. Evers-Birkenkamp, J.J. van Lith-Verhoeven, Y. Hesse, V.P. Hoppenreijs, R.F. Hommersom, A.M. Scholten, C.B. Hoyng, J.H. Klaver

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)126-133
JournalActa Ophthalmologica
Issue number2
Publication statusPublished - 2015

Cite this